Partner
Tax Credit/Community Development Finance; Real Estate/Business/Tax Law
About Brian
Brian’s practice focuses on representing financial institutions, developers, and other entities in transactions involving state and federal tax credits and other tax incentives. Brian also has experience advising buyers, sellers, and investors on tax aspects of mergers, acquisitions and joint ventures, and advising nonprofit corporations on governance and tax exemption matters.
In the tax credit and incentive space, Brian has represented investors, lenders, community development entities (CDEs), and developers in dozens of new markets tax credit transactions, including transactions twinned with other economic incentives. He also has expertise in historic rehabilitation tax credits (HTCs), having closed several transactions utilizing federal HTCs, as well as Virginia, Massachusetts, and Ohio HTCs, among others. He has assisted clients in structuring transactions to facilitate the use of low-income housing tax credits, renewable energy tax credits, and opportunity zone incentives.
Brian also has advised public companies, private equity firms, hedge funds, hospital systems, and strategic investors on partnership tax issues, executive compensation matters and the tax aspects of real estate investments (including the use of REITs), taxable stock and asset sales and purchases, and tax-free reorganizations. Brian has an active pro bono practice, having assisted several entities with obtaining 501(c)(3) status with the IRS.
Representative Matters
MoreLess- Represented a global medical technology company in the acquisition of a leading designer and manufacturer of fluid management systems for endoscopic procedures
- Represented a leading global credit specialist in a $250 million joint venture to acquire, finance and redevelop a multibuilding office complex in Miami, Florida
- Represented a multinational pharmaceutical and biotechnology company in its agreement to acquire a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases
- Represented a multinational pharmaceutical and biotechnology company in its acquisition of a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer
- Represented a national bank in connection with its financing of the rehabilitation of a historic building in Dallas, Texas
- Represented a national bank in connection with the financing of the construction of a charter school in New Orleans, Louisiana
- Represented a national bank in connection with its investment in the rehabilitation of an historic thread mill into a commercial and residential complex in Stonington, Connecticut
- Represented a national bank as investor and lender in the financing of a food bank’s construction of a new 29,000-square-foot administrative building in Fort Worth, Texas, generating new markets tax credits
- Represented a national bank in connection with its investment in the rehabilitation of an historic building located in Portland, Oregon, in partnership with a local college of art
In The News
MoreLess- No mention of IRC Section 50(d) income in IRA language adds complexity to transactions – In this article, Riemer & Braunstein partner Brian Hern discusses renewable energy tax credits in light of The Inflation Reduction Act of 2022.
Novogradac Journal of Tax Credits, February 2023